Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption

Journal of Global Antimicrobial Resistance

Volumn 11, Issue , 2017, Pages 71-74

  Pouwels, Koen B ^a,b,c   Batra, Rahul ^d   Patel, Amita ^d   Edgeworth, Jonathan D ^d   Robotham, Julie V ^a,c   Smieszek, Timo ^a,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimicrobial resistance; Bacterial infections; Escherichia coli

Indexed keywords

COTRIMOXAZOLE; SULFONAMIDE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; DRUG USE; ESCHERICHIA COLI; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; BLOOD; DRUG EFFECT; ENGLAND; ESCHERICHIA COLI INFECTION; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIMETHOPRIM; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 85030859576     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2017.07.013     Document Type: Article

References (20)

1. Goossens, H., Ferech, M., Vander Stichele, R., Elseviers, M., ESAC Project Group, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:February (9459) (2005), 579–587.
2. Garcia-Rey, C., Fenoll, A., Aguilar, L., Casal, J., Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother 54:August (2) (2004), 465–471.
3. Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., Hay, A.D., Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ, 340(May), 2010, c2096.
4. Andersson, D.I., Hughes, D., Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol 8:April (4) (2010), 260–271.
5. Levin, B.R., Minimizing potential resistance: a population dynamics view. Clin Infect Dis 33:September (Suppl. 3) (2001), S161–S169.
6. Enne, V.I., Livermore, D.M., Stephens, P., Hall, L.M., Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:April (9265) (2001), 1325–1328.
7. Bean, D.C., Livermore, D.M., Papa, I., Hall, L.M., Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother 56:November (5) (2005), 962–964.
8. Sundqvist, M., Reversibility of antibiotic resistance. Ups J Med Sci 119:May (2) (2014), 142–148.
9. Vernaz, N., Huttner, B., Muscionico, D., Salomon, J.L., Bonnabry, P., Lopez-Lozano, J.M., et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 66:April (4) (2011), 928–935.
10. Farra, A., Skoog, G., Wallen, L., Kahlmeter, G., Kronvall, G., Sorberg, M., et al. Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis 34:6 (2002), 449–455.
11. Sorberg, M., Farra, A., Ransjo, U., Gardlund, B., Rylander, M., Wallen, L., et al. Long-term antibiotic resistance surveillance of gram-negative pathogens suggests that temporal trends can be used as a resistance warning system. Scand J Infect Dis 34:5 (2002), 372–378.
12. Oteo, J., Lazaro, E., de Abajo, F.J., Baquero, F., Campos, J., Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 11:April (4) (2005), 546–553.
13. Veterinary Medicines Directorate. UK Veterinary Antibiotic Resistance and Sales Surveillance (UK-VARSS). Reports 2006–2014. https://www.gov.uk/government/publications/veterinary-antimicrobial-resistance-and-sales-surveillance-2014.
14. BSAC methods for antimicrobial susceptibility testing (http: www.bsac.org.uk/previous-versions). [Accessed 17 November 2016].
15. Bhaskaran, K., Gasparrini, A., Hajat, S., Smeeth, L., Armstrong, B., Time series regression studies in environmental epidemiology. Int J Epidemiol 42:4 (2013), 1187–1195.
16. Sundqvist, M., Geli, P., Andersson, D.I., Sjolund-Karlsson, M., Runehagen, A., Cars, H., et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 65:February (2) (2010), 350–360.
17. Huovinen, P., Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 32 (2001), 1608–1614.
18. Grape, M., Farra, A., Kronvall, G., Sundstrom, L., Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect 11:3 (2005), 185–192.
19. Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/575626/ESPAUR_Report_2016.pdf.
20. Cooke, J., Stephens, P., Ashiru-Oredope, D., Johnson, A.P., Livermore, D.M., Sharland, M., Antibacterial usage in English NHS hospitals as part of a national antimicrobial stewardship programme. Public Health 128 (2014), 693–697.